Cancer Biology & Medicine: 21 (4)

April 15, 2024; Volume 21,Issue 4

Editorial

Open Access
Hodgkin’s lymphoma: 2023 update on treatment
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang and Huilai Zhang

Cancer Biology & Medicine April 2024, 21 (4) 269-273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0427

Open Access
Neoantigen cancer vaccines: a new star on the horizon
Xiaoling Li, Jian You, Liping Hong, Weijiang Liu, Peng Guo and Xishan Hao

Cancer Biology & Medicine April 2024, 21 (4) 274-311; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0395
Open Access
Deciphering gastric inflammation-induced tumorigenesis through multi-omics data and AI methods
Qian Zhang, Mingran Yang, Peng Zhang, Bowen Wu, Xiaosen Wei and Shao Li

Cancer Biology & Medicine April 2024, 21 (4) 312-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0129

Open Access
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
Shuangcheng Li, Tianci Wang, Xinghui Xiao, Xiaodong Zheng, Haoyu Sun, Rui Sun, Hongdi Ma, Zhigang Tian and Xiaohu Zheng

Cancer Biology & Medicine April 2024, 21 (4) 331-346; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0341
Open Access
Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China
Jian Chen, Zhe Yang, Fengqiang Gao, Zhisheng Zhou, Junli Chen, Di Lu, Kai Wang, Meihua Sui, Zhengxin Wang, Wenzhi Guo, Guoyue Lyu, Haizhi Qi, Jinzhen Cai, Jiayin Yang, Shusen Zheng and Xiao Xu

Cancer Biology & Medicine April 2024, 21 (4) 347-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0453